In trading on Monday, shares of AcelRx Pharmaceuticals Inc (ACRX - Get Report) touched a new 52-week high of $5.50/share. That's a 182.05% rise, or $3.55 per share from the 52-week low of $1.95 set back on 06/12/2017. That means at today's intraday high, any investor who purchased ACRX stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, ACRX has seen 4 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
08/22/2017 Pamela P. Palmer Chief Medical Officer 10,000 $2.95 $29,487.00
08/24/2017 Mark G. Edwards Director 5,000 $3.02 $15,100.00
08/24/2017 Vincent J. Angotti Chief Executive Officer 15,000 $3.00 $45,000.00
09/11/2017 Raffi Asadorian Chief Financial Officer 7,000 $3.24 $22,705.20

The chart below shows where ACRX has traded over the past year, with the 50-day and 200-day moving averages included.

AcelRx Pharmaceuticals Inc Moving Averages Chart

In afternoon trading on Monday, ACRX shares are changing hands at $5.50/share, right at the new 52-week high.